Boston Scientific (NYSE:BSX) said it plans to use the proceeds of a $1.05 billion debt offering to retire some of its other debt coming due over the next few years.
Funding Roundup
A proverbial ‘Disneyland Sweepstakes’ in med device sends 1 company to AdvaMed 2013
It’s the proverbial "Disneyland Sweepstakes" in the medical device world: an all-expenses-paid trip to AdvaMed’s 2013 conference will go to 1 start-up company through a scholarship contest sponsored by RCT BioVentures.
The winner will have to prove true start-up chops – a company with a great technology but not a lot of walking-around money. Ideally, RCT BioVentures is looking to fund a company still in the pre-Series-A phase.
Boston Scientific, Covidien get in on SetPoint Medical’s $27M round
SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.
Tengion raises $74M for organ programs
Tengion (NSDQ:TNGN) said it raised $74.3 million from 22 unnamed investors as it puts a pair of clinical programs through their paces.
The Winston-Salem, N.C.-based medical device company is developing the Neo-Kidney Augment and Neo-Urinary Conduit, human organs that are grown using a bioabsorbable scaffold and patients’ own cells.
Diabetes: Freedom Meditech lands $7M to support non-invasive eye-based exams
Freedom Meditech roped in $7 million in a Series B financing round in support of 2 diagnostic products for diabetes management, 1 already on the shelves and 1 still on the bench.
ConforMIS raises $168M Series E round
ConforMIS closed a Series E round worth $167.7 million, raised from a consortium of 88 unnamed investors, according to regulatory filings.
The Bedford, Mass.-based medical device company makes personalized knee implants based on scans detailing patients’ physiology, creating customized instruments and implants that are shipped in a sterile package surgeons can open on the operating table.
Reached by MassDevice.com today, CEO Philipp Lang declined to comment on the company’s latest funding round.
NeuWave Medical zeros in on $19M in equity financing
Wisconsin medical device maker NeuWave Medical is more than halfway to wrapping up a hoped-for $19 million equity funding round, with $14 million in the bank so far and 22 accredited investors, according to an SEC filing.
The new filing offered more details on a fundraising round that began almost 1 year ago. As of yesterday, the ablation device company has about $5 million left to go to top off the fund-raise.
Hansen Medical pulls in $93M, shares surge 20% | Wall Street Beat
Hansen Medical (NSDQ:HNSN) said it inked an equity financing deal for up to $93 million with a consortium of investors including Oracle Investment Management and private equity player Jack Schuler, a co-founder of Crabtree Partners.
Diabetes: GI Dynamics pulls in $35M tranche in $52M round
GI Dynamics (ASX:GID) said it’s pulled in nearly $35 million as part of a $52 million funding round it’s planning to use to back a U.S. trial of its EndoBarrier device.
The Lexington, Mass.-based medical device company said in a regulatory filing that it’s drummed up $34.8 million from 13 unnamed investors.
Calif. PE firm looks to spend $310M fund on companies ‘on the verge’
San Francisco-based private equity firm Telegraph Hill Partners has gathered its largest fund to date and is looking to spend the $310 million raised on healthcare and life sciences companies that needs an extra push to make it big.
ReVision Optics sees $55M funding round
ReVision Optics said it’s raised $55 million from a consortium of investors and closed enrollment in a clinical trial of its Raindrop near vision inlay to treat presbyopia.